Acupuncture in Cancer Patients Undergoing Radiotherapy Treatment
Launched by ROYAL LONDON HOSPITAL FOR INTEGRATED MEDICINE · Feb 7, 2018
Trial Information
Current as of May 14, 2025
Completed
Keywords
ClinConnect Summary
The aim of the 'Acupuncture to improve quality of life and fatigue in cancer patients undergoing Radiotherapy Treatment' (ART) project is to investigate all aspects of the feasibility of undertaking clinical research on acupuncture with patients having radiotherapy at the University College Hospital (UCH) Cancer division.
The program includes an exploratory feasibility randomized controlled trial to investigate all aspects of a future definitive randomized controlled trial, including: organizational and procedural issues, patient group (including cancer diagnosis and stage), statistical po...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients due to receive radical (curative) radiotherapy
- • Patients of either gender and older than 16 years old.
- • Patients with any cancer diagnosis.
- • Patients willing to participate in the study and be randomised to one of the two treatment arms.
- • Patients willing to attend at least 3 acupuncture treatments if assigned to the acupuncture intervention.
- • Palliative patients.
- • Patients unwilling to participate (for instance due to needle phobia).
- • Patients currently receiving acupuncture.
- • Patients with a platelet count \<20 000mm.
- • Patients with a white blood cell count \<1000mm.
- • Patients with severe clotting dysfunction or who bruise spontaneously.
- • Patients unable to complete the questionnaires as judged by the investigators.
- Exclusion Criteria:
- • -
About Royal London Hospital For Integrated Medicine
The Royal London Hospital for Integrated Medicine (RLHIM) is a leading institution dedicated to advancing the field of integrated healthcare through innovative clinical trials and research. As part of the NHS, RLHIM combines conventional medicine with complementary therapies, focusing on holistic patient care and evidence-based practices. The hospital aims to enhance the understanding and effectiveness of integrated treatment modalities, contributing to the improvement of patient outcomes across a diverse range of health conditions. With a commitment to rigorous scientific inquiry and a patient-centered approach, RLHIM plays a pivotal role in shaping the future of integrated medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Trial Officials
Peter A Fisher, MD
Principal Investigator
Royal London Hospital for Integrated Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials